Evidence map›Paper›PMID 32087680›Full record

ArticleBMC infectious diseases2020

Computational MHC-I epitope predictor identifies 95% of experimentally mapped HIV-1 clade A and D epitopes in a Ugandan cohort.

Daniel Lule Bugembe, Andrew Obuku Ekii, Nicaise Ndembi, Jennifer Serwanga, Pontiano Kaleebu, Pietro Pala

Abstract read
In one paragraph

Article in BMC infectious diseases, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Immunoinformatics: Predicting Peptide-MHC Binding.Annual review of biomedical data science · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Daniel Lule BugembeMRC/UVRI and LSHTM Uganda Research Unit, P. O. Box 49, Plot 51-59 Nakiwogo Road, Entebbe, Uganda. dan.lule@mrcuganda.org.ORCID http://orcid.org/0000-0002-5616-515X
Andrew Obuku EkiiMRC/UVRI and LSHTM Uganda Research Unit, P. O. Box 49, Plot 51-59 Nakiwogo Road, Entebbe, Uganda.
Nicaise NdembiInstitute of Human Virology, Abuja, Nigeria.
Jennifer SerwangaMRC/UVRI and LSHTM Uganda Research Unit, P. O. Box 49, Plot 51-59 Nakiwogo Road, Entebbe, Uganda.
Pontiano KaleebuMRC/UVRI and LSHTM Uganda Research Unit, P. O. Box 49, Plot 51-59 Nakiwogo Road, Entebbe, Uganda.
Pietro PalaMRC/UVRI and LSHTM Uganda Research Unit, P. O. Box 49, Plot 51-59 Nakiwogo Road, Entebbe, Uganda.

Funding

European and Developing Countries Clinical Trials Partnership TA_05_40200_40203Medical Research Council MC_UU_00027/1UK Medical Research Council (MRC) and the UK Department for International Development (DFID) under the MRC/DFID Concordat agreement, the Wellcome Trust WT078927MAWellcome Trust
6 · The paper itself

Abstract

backgroundIdentifying immunogens that induce HIV-1-specific immune responses is a lengthy process that can benefit from computational methods, which predict T-cell epitopes for various HLA types.

methodsWe tested the performance of the NetMHCpan4.0 computational neural network in re-identifying 93 T-cell epitopes that had been previously independently mapped using the whole proteome IFN-γ ELISPOT assays in 6 HLA class I typed Ugandan individuals infected with HIV-1 subtypes A1 and D. To provide a benchmark we compared the predictions for NetMHCpan4.0 to MHCflurry1.2.0 and NetCTL1.2.

resultsNetMHCpan4.0 performed best correctly predicting 88 of the 93 experimentally mapped epitopes for a set length of 9-mer and matched HLA class I alleles. Receiver Operator Characteristic (ROC) analysis gave an area under the curve (AUC) of 0.928. Setting NetMHCpan4.0 to predict 11-14mer length did not improve the prediction (37-79 of 93 peptides) with an inverse correlation between the number of predictions and length set. Late time point peptides were significantly stronger binders than early peptides (Wilcoxon signed rank test: p = 0.0000005). MHCflurry1.2.0 similarly predicted all but 2 of the peptides that NetMHCpan4.0 predicted and NetCTL1.2 predicted only 14 of the 93 experimental peptides.

conclusionNetMHCpan4.0 class I epitope predictions covered 95% of the epitope responses identified in six HIV-1 infected individuals, and would have reduced the number of experimental confirmatory tests by > 80%. Algorithmic epitope prediction in conjunction with HLA allele frequency information can cost-effectively assist immunogen design through minimizing the experimental effort.

Indexed as

AdolescentAdultChildCohort StudiesComputational BiologyEnzyme-Linked Immunospot AssayEpitope MappingEpitopes, T-LymphocyteFemaleHistocompatibility Antigens Class IHIV-1HIV InfectionsHumansMaleMiddle AgedNeural Networks, ComputerEpitopes, T-LymphocyteHistocompatibility Antigens Class IPeptidesArtificial neural networkEpitope mappingHIV-1In-silicoMHCflurry1.2.0 and NetCTL1.2NetMHCpan4.0.T-cell

Identifiers

PMID32087680
PMCPMC7036183

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.